Cargando…
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
BACKGROUND: Varenicline, a new treatment for smoking cessation, has demonstrated significantly greater efficacy over placebo and sustained release bupropion (bupropion SR). A study was undertaken to compare a 12-week standard regimen of varenicline with a 10-week standard regimen of transdermal nico...
Autores principales: | Aubin, H-J, Bobak, A, Britton, J R, Oncken, C, Billing, C B, Gong, J, Williams, K E, Reeves, K R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569194/ https://www.ncbi.nlm.nih.gov/pubmed/18263663 http://dx.doi.org/10.1136/thx.2007.090647 |
Ejemplares similares
-
The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records
por: Taylor, Gemma MJ, et al.
Publicado: (2017) -
Does smoking cessation with varenicline worsen vascular endothelial function?
por: Umeda, Akira, et al.
Publicado: (2013) -
What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study
por: Davies, Neil M, et al.
Publicado: (2015) -
The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trial
por: Gobarani, Rukshar Kaizerali, et al.
Publicado: (2020) -
Combination of varenicline and nicotine patch for smoking cessation: A case report
por: Young, Kelly M., et al.
Publicado: (2019)